Hydrocodone Bitartrate And Homatropine Methylbromide recalls
Hydrocodone Bitartrate And Homatropine Methylbromide products have been recalled 3 times, most recently on 26 May 2021. The recalling company is usually KVK-Tech. The most common reason is potency & assay.
Total recalls3since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 26 May 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why hydrocodone bitartrate and homatropine methylbromide is recalled
Companies
Product types
By year
All hydrocodone bitartrate and homatropine methylbromide recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Hydrocodone Bitartrate and Homatropine Methlybromide recalledHydrocodone Bitartrate And Homatropine Methylbromide | KVK-Tech | Potency & Assay | Nationwide |
| Drug | CLASS II | Hydrocodone Bitartrate and Homatropine Methlybromide Oral recalledHydrocodone Bitartrate And Homatropine Methylbromide | KVK-Tech | Particulate Matter | Nationwide |
| Drug | CLASS III | Lupin Hydrocodone Bitartrate recalled by Novel LaboratoriesHydrocodone Bitartrate And Homatropine Methylbromide | Novel Laboratories | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.